-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
.
The companies will collaborate to explore synergies between Germains' seed osmotic and coating technology and GreenLight's dsRNA expertise and cost-effective scale-up production to protect vegetable crops
.
GreenLight announced in October 2021 that it was the first to achieve effective field control of fungal pathogens using double-stranded RNA
.
.
GreenLight announced in October 2021 that it was the first to achieve effective field control of fungal pathogens using double-stranded RNA
.
"Farmers and agribusinesses are always looking for effective, affordable, and sustainable alternatives to conventional crop protection, especially in light of increasing environmental and market pressures," said Mark Mark, Senior Vice President, Technology and External Innovation, GreenLight Singleton said
.
.
He said: "We are excited to be working with Germains' outstanding seed treatment experts to develop other potential applications of RNA to address these challenges
.
Our facility in Rochester, NY has the ability to produce high-quality RNA at low cost and at scale, which It means we have the ability to rapidly commercialize and scale new products in our pipeline
.
"
.
Our facility in Rochester, NY has the ability to produce high-quality RNA at low cost and at scale, which It means we have the ability to rapidly commercialize and scale new products in our pipeline
.
"
"Germains Seed Technologies has been a leader in the international seed industry for 150 years
.
Our strength is derived from our commitment to innovation
.
We strive to maximize nature's potential and meet the needs of our customers," Germains Business Development and Research Director Dale Krolikowski said
.
.
Our strength is derived from our commitment to innovation
.
We strive to maximize nature's potential and meet the needs of our customers," Germains Business Development and Research Director Dale Krolikowski said
.
"We believe this new collaboration with GreenLight Biosciences enables the creation of a new generation of this product.
RNA technology offers enormous potential for the seed treatment industry
.
We are excited to partner with GreenLight's innovators to move the industry forward
.
"
RNA technology offers enormous potential for the seed treatment industry
.
We are excited to partner with GreenLight's innovators to move the industry forward
.
"
GreenLight's technology complements Germains' Health brand
.
The Health brand has launched several novel seed treatment products over the past few years, including Ultim ® -ST , an organic product for Pythium control
.
Seed- and soil-borne pathogens cause huge crop losses each year, and Germains has been working to address such diseases
.
This collaboration will allow Germains to offer further innovations to its customers
.
.
The Health brand has launched several novel seed treatment products over the past few years, including Ultim ® -ST , an organic product for Pythium control
.
Seed- and soil-borne pathogens cause huge crop losses each year, and Germains has been working to address such diseases
.
This collaboration will allow Germains to offer further innovations to its customers
.
The seed treatment market is valued at nearly $6.
5 billion and is growing rapidly with an estimated annual growth rate of between 10% and 12%
.
If successful, this collaboration will be an important addition to GreenLight's product portfolio and future agri-product pipeline, as well as a key addition to Germains' innovative seed treatment and grower solutions
.
5 billion and is growing rapidly with an estimated annual growth rate of between 10% and 12%
.
If successful, this collaboration will be an important addition to GreenLight's product portfolio and future agri-product pipeline, as well as a key addition to Germains' innovative seed treatment and grower solutions
.
GreenLight expects its RNA-based product to control the Colorado potato beetle to receive U.
S.
regulatory approval in 2022
.
The company also plans to submit its bee health solution to the EPA this year
.
GreenLight has seven agricultural products in development and plans to launch by 2026 with a potential market of $6 billion
.
S.
regulatory approval in 2022
.
The company also plans to submit its bee health solution to the EPA this year
.
GreenLight has seven agricultural products in development and plans to launch by 2026 with a potential market of $6 billion
.
